Neurogen Corp. (NRGN1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
35 NORTHEAST INDUSTRIAL RD BRANFORD, CT 06405

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Neurogen Corp operates as a drug discovery and development company and targets new small molecule drugs for therapeutic use with inflammation, pain, insomnia, depression, anxiety, obesity and other disorders.

View SEC Filings from NRGN1 instead.

View recent insider trading info

Funds Holding NRGN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NRGN1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WARBURG PINCUS PRIVATE EQUITY VIII L P

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

WARBURG PINCUS & CO

KAYE CHARLES R

LANDY JOSEPH

  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2009-12-23 0

HEN STEWART

  • SEE REMARKS
No longer subject to file 2009-12-23 0

SIMON JOHN

  • Director
0 2009-12-15 0

BAKER JULIAN

  • Director
0 2009-12-15 0

SAXTON CRAIG

  • Director
0 2009-12-15 0

LAMATTINA JOHN L

  • Director
0 2009-12-15 0

BROSHY ERAN

  • Director
0 2009-12-15 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
3,500,059 2008-07-25 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
690,856 2008-07-25 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
335,668 2008-07-25 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
3,678,823 2008-07-25 0

DAVIS STEPHEN PRESIDENT, CEO

  • Officer
  • Director
0 2008-07-25 0

LEFF JONATHAN S

  • Director
13,571,411 2008-07-25 0

PITLER THOMAS A. SVP, CBO AND CFO

  • Officer
0 2008-07-25 0

STANKOVIC SRDJAN R. EXEC VP AND CDO

  • Officer
0 2008-07-25 0

BAKER FELIX

  • Director
0 2008-06-15 0

HUTCHISON ALAN EXEC VP DISCOVERY RESEARCH

  • Officer
18,375 2007-12-20 0

KOSTER WILLIAM H CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
31,500 2007-12-20 0

KRAUSE JAMES SENIOR VP BIOLOGY

  • Officer
15,750 2007-12-20 0

CHENARD BERTRAND L SR VP, CHEMISTRY

  • Officer
5,781 2007-06-11 0

UDEN STEPHEN EXEC VP, RESEARCH & DEVELOPMEN

  • Officer
90,000 2007-01-17 0

DILL JEFFREY VP AND GENERAL COUNSEL

  • Officer
40,000 2007-01-17 0

OCHOA RICARDO VP, PRE-CLINICAL SAFETY

  • Officer
0 2006-09-25 0

NOVITCH MARK M D

  • Director
2,500 2006-03-15 0

BUTLER ROBERT N

  • Director
2,500 2006-03-15 0

WOOLSEY SUZANNE

  • Director
2,500 2006-03-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments